Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Baghdadi

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2016
Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cellsMasatoshi Kanda, Hiroyuki Yamanaka, Satoshi Kojo, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 14, 2018
Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphomaYoshihiro Komohara, Osamu Noyori, Yoichi Saito, et al.
Immunological Medicine|November 26, 2019
Prognostic value of IL-34 in colorectal cancer patientsTakuto Kobayashi, Muhammad Baghdadi, Nanumi Han, et al.
Scientific Reports|January 12, 2018
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Hiraku Endo, Atsushi Takano, et al.
Iscience|November 18, 2020
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.
Iscience|January 14, 2022
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.
Immunity|December 10, 2013
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune toleranceMuhammad Baghdadi, Akihiro Yoneda, Tsunaki Yamashina, et al.
Cancer Research|May 9, 2015
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic CancerShintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa, et al.
Nature Immunology|July 31, 2012
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, et al.
Cancer Research|August 24, 2016
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer CellsMuhammad Baghdadi, Haruka Wada, Sayaka Nakanishi, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2016
Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cellsMasatoshi Kanda, Hiroyuki Yamanaka, Satoshi Kojo, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|December 14, 2018
Potential anti-lymphoma effect of M-CSFR inhibitor in adult T-cell leukemia/lymphomaYoshihiro Komohara, Osamu Noyori, Yoichi Saito, et al.
Immunological Medicine|November 26, 2019
Prognostic value of IL-34 in colorectal cancer patientsTakuto Kobayashi, Muhammad Baghdadi, Nanumi Han, et al.
Scientific Reports|January 12, 2018
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Hiraku Endo, Atsushi Takano, et al.
Iscience|November 18, 2020
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.
Iscience|January 14, 2022
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Takuto Kobayashi, Nanumi Han, et al.
Immunity|December 10, 2013
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune toleranceMuhammad Baghdadi, Akihiro Yoneda, Tsunaki Yamashina, et al.
Cancer Research|May 9, 2015
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic CancerShintaro Takeuchi, Muhammad Baghdadi, Takahiro Tsuchikawa, et al.
Nature Immunology|July 31, 2012
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1Shigeki Chiba, Muhammad Baghdadi, Hisaya Akiba, et al.
Cancer Research|August 24, 2016
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer CellsMuhammad Baghdadi, Haruka Wada, Sayaka Nakanishi, et al.
Pageof 4